PRESS RELEASE

Nucleus Research Announces the 2019 Technology ROI Awards

Jul 9, 2019

Technology deployments continue to deliver significant return-on-investment

BOSTON–(BUSINESS WIRE)–Today, Nucleus Research announced the top 10 technology deployments of 2019 with the winners of the Technology ROI Awards.

The Technology ROI Awards recognize this year’s success stories based on the overall value delivered. Nucleus analysts perform an independent ROI assessment to calculate the actual business benefits. The winners are chosen from more than 100 nominees, based strictly on the ROI achieved.

“This year’s top 10 winners continue to show that technology delivers the highest return of any investment a corporation can consider” said Ian Campbell, Nucleus Research Chief Executive Officer. “Technology delivers ROI to every corner of the organization, whether through increasing the productivity of workers, reducing costly or manual tasks, or optimizing processes to reduce waste.”

This year’s technology ROI Award winners are:

Experian, for its implementation of Visier, with an ROI of 1200%
Sunrise Senior Living, for its implementation of Saba, with an ROI of 1043%
Spirit Airlines, for its implementation of TalentQuest, with an ROI of 979%
PFCU, for its implementation of Datawatch, with an ROI of 923%
SAP Data Services Bureau, for its implementation of SAP Enterprise Data Management Engine, with an ROI of 830%
Hyland, for its implementation of FinancialForce, with an ROI of 695%
VMWare, for its implementation of Salesforce, with an ROI of 641%
Room to Read, for its implementation of Sage Intacct, with an ROI of 402%
Company Nurse, for its implementation of Genesys, with an ROI of 269%
MacDonald Miller, for its implementation of Microsoft Dynamics 365, with an ROI of 282%

Find additional information at ROIAwards.com and nucleusresearch.com.

About Nucleus Research

Nucleus Research is a global provider of investigative, case-based technology research and advisory services. We deliver the numbers that drive business decisions. For more information, visit NucleusResearch.com or follow us on Twitter @NucleusResearch.